Zevra Therapeutics Inc (ZVRA)
4.76
-0.06
(-1.24%)
USD |
NASDAQ |
May 16, 16:00
4.77
+0.01
(+0.21%)
After-Hours: 20:00
Zevra Therapeutics Price to Book Value: 4.081 for May 16, 2024
Price to Book Value Chart
Historical Price to Book Value Data
| Date | Value |
|---|---|
| May 16, 2024 | 4.081 |
| May 15, 2024 | 4.132 |
| May 14, 2024 | 4.115 |
| May 13, 2024 | 4.192 |
| May 10, 2024 | 4.132 |
| May 09, 2024 | 4.312 |
| May 08, 2024 | 4.424 |
| May 07, 2024 | 4.437 |
| May 06, 2024 | 4.420 |
| May 03, 2024 | 4.124 |
| May 02, 2024 | 4.072 |
| May 01, 2024 | 3.944 |
| April 30, 2024 | 3.926 |
| April 29, 2024 | 3.901 |
| April 26, 2024 | 3.875 |
| April 25, 2024 | 3.875 |
| April 24, 2024 | 3.909 |
| April 23, 2024 | 3.926 |
| April 22, 2024 | 3.918 |
| April 19, 2024 | 3.875 |
| April 18, 2024 | 3.858 |
| April 17, 2024 | 3.978 |
| April 16, 2024 | 4.089 |
| April 15, 2024 | 4.102 |
| April 12, 2024 | 4.115 |
| Date | Value |
|---|---|
| April 11, 2024 | 4.235 |
| April 10, 2024 | 4.218 |
| April 09, 2024 | 4.055 |
| April 08, 2024 | 4.235 |
| April 05, 2024 | 4.132 |
| April 04, 2024 | 4.209 |
| April 03, 2024 | 4.312 |
| April 02, 2024 | 4.385 |
| April 01, 2024 | 4.424 |
| March 31, 2024 | |
| March 28, 2024 | 3.924 |
| March 27, 2024 | 4.018 |
| March 26, 2024 | 3.870 |
| March 25, 2024 | 3.815 |
| March 22, 2024 | 3.897 |
| March 21, 2024 | 3.921 |
| March 20, 2024 | 4.055 |
| March 19, 2024 | 3.995 |
| March 18, 2024 | 4.002 |
| March 15, 2024 | 4.028 |
| March 14, 2024 | 4.129 |
| March 13, 2024 | 4.216 |
| March 12, 2024 | 4.190 |
| March 11, 2024 | 4.116 |
| March 08, 2024 | 4.096 |
Price to Book Ratio Definition
Price to book value is a valuation ratio that is measured by stock price / book value per share. The book value is essentially the tangible accounting value of a firm compared to the market value that is shown.
Price to Book Value Range, Past 5 Years
1.139
Minimum
May 11 2022
5.753
Maximum
Jun 23 2021
2.565
Average
2.447
Median
Price to Book Value Benchmarks
| OptiNose Inc | -- |
| Perspective Therapeutics Inc | 11.94 |
| Dare Bioscience Inc | -- |
| Kodiak Sciences Inc | 0.7393 |
| INmune Bio Inc | 7.614 |
Price to Book Value Related Metrics
| PS Ratio | 6.456 |
| PEG Ratio | -0.1631 |
| Price | 4.76 |
| Earnings Yield | -28.36% |
| Market Cap | 199.22M |
| PEGY Ratio | -0.1631 |